{
    "2018-12-11": [
        [
            {
                "time": "2018-03-15",
                "original_text": "What Seattle Genetics’ Bottom-Line Trend Indicates",
                "features": {
                    "keywords": [
                        "Seattle Genetics",
                        "Bottom-Line",
                        "Trend"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Understanding Seattle Genetics’ Operational Performance",
                "features": {
                    "keywords": [
                        "Seattle Genetics",
                        "Operational",
                        "Performance"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "How’s Seattle Genetics Positioned?",
                "features": {
                    "keywords": [
                        "Seattle Genetics",
                        "Positioned"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Bristol-Myers to Study Opdivo in Combo With Vedanta's VE800",
                "features": {
                    "keywords": [
                        "Bristol-Myers",
                        "Opdivo",
                        "Vedanta",
                        "VE800"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "AXON Throws In The Towel On Nelotanserin, MNLO On Watch, VYGR Sails Ahead",
                "features": {
                    "keywords": [
                        "AXON",
                        "Nelotanserin",
                        "MNLO",
                        "VYGR"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}